Potential therapeutic options for COVID-19: an update on current evidence
Abstract SARS-CoV-2, a novel coronavirus, is the agent responsible for the COVID-19
pandemic and is a major public health concern nowadays. The rapid and global spread of …
pandemic and is a major public health concern nowadays. The rapid and global spread of …
Zinc and selenium supplementation in COVID-19 prevention and treatment: a systematic review of the experimental studies
E Balboni, F Zagnoli, T Filippini… - Journal of Trace …, 2022 - Elsevier
Background and aim The COVID-19 pandemic has severely affected the world's population
in the last two years. Along with non-pharmacological public health interventions, major …
in the last two years. Along with non-pharmacological public health interventions, major …
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment
E Terpos, M Gavriatopoulou… - Blood Cancer …, 2021 - nature.com
Recent data suggest a suboptimal antibody response to COVID-19 vaccination in patients
with hematological malignancies. Neutralizing antibodies (NAbs) against SARS-CoV-2 were …
with hematological malignancies. Neutralizing antibodies (NAbs) against SARS-CoV-2 were …
Anemia in patients with Covid-19: pathogenesis and clinical significance
G Bergamaschi, F Borrelli de Andreis, N Aronico… - Clinical and …, 2021 - Springer
COVID-19 patients typically present with lower airway disease, although involvement of
other organ systems is usually the rule. Hematological manifestations such as …
other organ systems is usually the rule. Hematological manifestations such as …
Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose
E Terpos, IP Trougakos… - Blood, The Journal …, 2021 - ashpublications.org
Patients with multiple myeloma (MM) are at an increased risk for infection because of their
immunocompromised state, old age, and comorbidities. 1 Coronavirus disease 2019 …
immunocompromised state, old age, and comorbidities. 1 Coronavirus disease 2019 …
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)
In the post-pandemic COVID-19 period, human activities have returned to normal and
COVID-19 cases are usually mild. However, patients with multiple myeloma (MM) present an …
COVID-19 cases are usually mild. However, patients with multiple myeloma (MM) present an …
COVID-19 in joint ageing and osteoarthritis: current status and perspectives
COVID-19 is a trending topic worldwide due to its immense impact on society. Recent trends
have shifted from acute effects towards the long-term morbidity of COVID-19. In this review …
have shifted from acute effects towards the long-term morbidity of COVID-19. In this review …
Post-acute COVID-19 syndrome and kidney diseases: what do we know?
COVID-19, a disease caused by a novel coronavirus (SARS-CoV-2), is a major global threat
that has turned into a pandemic. Despite the emergence of multiple vaccination alternatives …
that has turned into a pandemic. Despite the emergence of multiple vaccination alternatives …
Vitamin C supplementation for the treatment of COVID-19: A systematic review and meta-analysis
M Olczak-Pruc, D Swieczkowski, JR Ladny, M Pruc… - Nutrients, 2022 - mdpi.com
Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, caused by the
severe respiratory syndrome coronavirus 2 (SARS-CoV-2), millions of people have died …
severe respiratory syndrome coronavirus 2 (SARS-CoV-2), millions of people have died …
SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma …
Elucidating the characteristics of human immune response against SARS-CoV-2 is of high
priority and relevant for determining vaccine strategies. We report the results of a follow-up …
priority and relevant for determining vaccine strategies. We report the results of a follow-up …